Christopher M. O’Connor
Duke University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Heart Failure Treatment and Management
Strong evidence · 2 supporting papers · latest 2026
Parathyroid Disorders and Treatments
Solid evidence · 1 supporting paper · latest 2026
Health Systems, Economic Evaluations, Quality of Life
Supporting evidence · 1 supporting paper · latest 2026
Advanced Causal Inference Techniques
Supporting evidence · 1 supporting paper · latest 2026
Atrial Fibrillation Management and Outcomes
Supporting evidence · 1 supporting paper · latest 2026
Magnesium in Health and Disease
Supporting evidence · 1 supporting paper · latest 2026
Cystic Fibrosis Research Advances
Supporting evidence · 1 supporting paper · latest 2026
Medication Adherence and Compliance
Supporting evidence · 1 supporting paper · latest 2026
Publications (3)
Efficacy of vericiguat by background guideline-directed medical therapy in the VICTOR trial
2026DOI
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial
2026DOI
MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Duke University
Source: ScienceWe Extractor · retrieved 2026-09-27